This monoclonal antibody (MAb), when used in conjunction with the MAb specific to CYP3A7 clone F19 P2 H2, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7.
| Inventor | Institute |
|---|---|
| Ayham Alnabulsi | Vertebrate Antibodies Limited |
| Cat. #: | 151863 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction;Metabolism;Tissue-specific biology |
| Application: | IHC ; WB ; ELISA ; IHC ; WB |
| Target: | CYP3A5- Cytochrome P450 3A5 (EC 1.14.14.1) (niphedipine oxidase), (CYPIIIA5) (P450-PCN3) (HLp2). |
| Reactivity: | Human |
| Clone: | F18P3B6 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | This monoclonal antibody (MAb), when used in conjunction with the MAb specific to CYP3A7 clone F19 P2 H2, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Immunogen: | Ovalbumin-conjugated synthetic peptide DSRDGTLSGE (C-terminal sequence) |
| Myeloma used: | P3X63Ag8.653 |
| Target background: | This monoclonal antibody (MAb), when used in conjunction with the MAb specific to CYP3A7 clone F19 P2 H2, is able to differentiate between the CYP450 family 3 members: CYP3A5 and CYP3A7. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Zia et al. 2015. Int J Exp Pathol. 96(2):81-6. PMID: 25670065. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation. Murray et al. 2010. Histopathology. 57(2):202-11. PMID: 20716162. Profiling the expression of cytochrome P450 in breast cancer. Downie et al. 2005. Clin Cancer Res. 11(20):7369-75. PMID: 16243809. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Kumarakulasingham et al. 2005. Clin Cancer Res. 11(10):3758-65. PMID: 15897573. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Kosik et al. 1992. Science. 256(5058):780-3. PMID: 1589757. Alzheimer's disease: a cell biological perspective. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.